课题基金 / 基金详情

Lung cancer therapy using genetically modified macrophages

Lung cancer therapy using genetically modified macrophages
使用转基因巨噬细胞治疗肺癌
批准号:
488420
负责人:
Post Martin
金额:
$71.33万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-09-01 至 2028-09-01

项目摘要

项目成果

Post Martin的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lung cancer remains the leading cause of cancer death worldwide. Current therapies have not been effective in curbing this death rate. New therapies are urgently needed. We have created special lung immune cells in the lab from stem cells that are designe
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lung Development, Injury and Repair
  • 批准号:
    312099
  • 项目类别:
    Operating Grants
  • 资助金额:
    $172.95万
  • 财政年份:
    2014
  • 负责人:
    Post Martin
  • 依托单位:
CRC Tier 1
  • 批准号:
    314139
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2013
  • 负责人:
    Post Martin
  • 依托单位:
Effect of mechanical forces on lung development
Epithelial-mesenchymal (endothelial)interactions regulate postnatal lung development